{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T20:29:32Z","timestamp":1792873772275,"version":"4.5.0"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","prd-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.parkreldis.2016.09.011","type":"journal-article","created":{"date-parts":[[2016,9,13]],"date-time":"2016-09-13T11:00:46Z","timestamp":1473764446000},"page":"127-129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Orthostatic hypotension predicts motor decline in early Parkinson disease"],"prefix":"10.1016","volume":"32","author":[{"given":"Vikas","family":"Kotagal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Lineback","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolaas I.","family":"Bohnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger L.","family":"Albin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.parkreldis.2016.09.011_bib1","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1212\/WNL.0000000000002086","article-title":"Survival in synucleinopathies: a prospective cohort study","volume":"85","author":"Goldstein","year":"2015","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.parkreldis.2016.09.011_bib2","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/S1474-4422(09)70291-1","article-title":"Progression of Parkinson's disease in the clinical phase: potential markers","volume":"8","author":"Maetzler","year":"2009","journal-title":"Lancet Neurol."},{"issue":"15","key":"10.1016\/j.parkreldis.2016.09.011_bib3","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1001\/jama.284.15.1931","article-title":"Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial","volume":"284","year":"2000","journal-title":"Jama"},{"issue":"1","key":"10.1016\/j.parkreldis.2016.09.011_bib4","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/00002826-200001000-00007","article-title":"A\u00a0randomized controlled trial comparing pramipexole with levodopa in early Parkinson's disease: design and methods of the CALM-PD Study","volume":"23","year":"2000","journal-title":"Clin. Neuropharmacol."},{"issue":"12","key":"10.1016\/j.parkreldis.2016.09.011_bib5","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.parkreldis.2015.10.018","article-title":"Cerebral autoregulation and white matter lesions in Parkinson's disease and multiple system atrophy","volume":"21","author":"Indelicato","year":"2015","journal-title":"Park. Relat. Disord."},{"issue":"17","key":"10.1016\/j.parkreldis.2016.09.011_bib6","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1212\/WNL.0000000000000356","article-title":"Modifiable cardiovascular risk factors and axial motor impairments in Parkinson disease","volume":"82","author":"Kotagal","year":"2014","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.parkreldis.2016.09.011_bib7","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1001\/jamaneurol.2015.0703","article-title":"New clinical subtypes of Parkinson disease and their longitudinal progression: a prospective cohort comparison with other phenotypes","volume":"72","author":"Fereshtehnejad","year":"2015","journal-title":"JAMA Neurol."},{"issue":"2","key":"10.1016\/j.parkreldis.2016.09.011_bib8","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1468-1331.2012.03819.x","article-title":"The potential prognostic role of cardiovascular autonomic failure in alpha-synucleinopathies","volume":"20","author":"Fanciulli","year":"2013","journal-title":"Eur. J. Neurol."},{"issue":"3","key":"10.1016\/j.parkreldis.2016.09.011_bib9","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/mds.26076","article-title":"Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease","volume":"30","author":"Erro","year":"2015","journal-title":"Mov. Disord. Of. J. Mov. Disord. Soc."},{"issue":"Suppl 1","key":"10.1016\/j.parkreldis.2016.09.011_bib10","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.parkreldis.2015.09.027","article-title":"Non motor subtypes and Parkinson's disease","volume":"22","author":"Sauerbier","year":"2016","journal-title":"Park. Relat. Disord."},{"issue":"3","key":"10.1016\/j.parkreldis.2016.09.011_bib11","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.parkreldis.2011.10.016","article-title":"Body mass index in Parkinson's disease: a meta-analysis","volume":"18","author":"van der Marck","year":"2012","journal-title":"Park. Relat. Disord."},{"issue":"1","key":"10.1016\/j.parkreldis.2016.09.011_bib12","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.archger.2011.06.022","article-title":"Relationship between changes of body mass index (BMI) and cognitive decline in Parkinson's disease (PD)","volume":"55","author":"Kim","year":"2012","journal-title":"Arch. Gerontol. Geriatr."},{"issue":"8","key":"10.1016\/j.parkreldis.2016.09.011_bib13","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/mds.21502","article-title":"Low plasma uric acid level in Parkinson's disease. Movement disorders","volume":"22","author":"Annanmaki","year":"2007","journal-title":"Of. J. Mov. Disord. Soc."},{"issue":"3","key":"10.1016\/j.parkreldis.2016.09.011_bib14","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1001\/archneur.57.3.369","article-title":"The evolution of diagnosis in early Parkinson disease. Parkinson Study Group","volume":"57","author":"Jankovic","year":"2000","journal-title":"Arch. Neurol."}],"container-title":["Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802016303364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802016303364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T09:55:17Z","timestamp":1536400517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802016303364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":14,"alternative-id":["S1353802016303364"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2016.09.011","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Orthostatic hypotension predicts motor decline in early Parkinson disease","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2016.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}